CHEPLAPHARM is a family-owned company headquartered in Greifswald, Germany. For more than 20 years, the company has been very successful in taking over well-known and well-established medicines from the research-based pharmaceutical industry and transferring them to an existing global network of partners for manufacturing and distribution.

CHEPLAPHARM is represented in more than 145 countries worldwide with more than 3,260 registrations. The company relies on a large and diverse network of over 125 contract manufacturing organisations or active ingredient suppliers and more than 100 distribution partners. CHEPLAPHARM thus ensures the continuous supply of these medicines to patients worldwide.

In this way, CHEPLAPHARM ensures the continuous supply of these medicines to patients worldwide. In addition to its headquarters in Greifswald, CHEPLAPHARM operates further sites in France, Japan, Russia and Switzerland. The company employs around 650 people worldwide. The affiliate in Switzerland was established in 2023 to further drive the growth of the group and global acquisitions of established medicines from large pharmaceutical companies for the entire CHEPLAPHARM group. 

Find out more